Square Pharmaceuticals Limited

Square Pharmaceuticals Limited, established in 1958, stands as a cornerstone of the pharmaceutical and healthcare industry in Bangladesh. The company specializes in the research, development, and large-scale manufacturing of a diverse portfolio of pharmaceutical products, including antibiotics and various therapeutic agents. By adhering to international quality standards, the firm has solidified its reputation as a leading manufacturer within the region, consistently delivering high-grade medical solutions to meet evolving healthcare demands.

Operating with a robust workforce of 5,000-10,000 employees, Square Pharmaceuticals Limited maintains a sophisticated operational footprint across 2 primary locations. The company leverages state-of-the-art manufacturing facilities to produce active pharmaceutical ingredients (API) and finished dosage forms. These facilities are designed to comply with rigorous global manufacturing protocols, ensuring that every product meets stringent safety and efficacy benchmarks. The organization’s commitment to technical excellence is reflected in its advanced production capabilities and its strategic focus on maintaining high-quality output across its entire supply chain.

The company’s market influence extends beyond domestic borders, as it actively engages in the export of pharmaceutical products to international markets. By integrating advanced technology with deep industry expertise, Square Pharmaceuticals Limited continues to drive innovation in the healthcare sector. Meet Square Pharmaceuticals Limited's team to gain insights into the leadership and professional expertise driving these operations. With over six decades of experience, the firm remains dedicated to enhancing public health outcomes through reliable, high-quality pharmaceutical manufacturing and distribution strategies that serve both local and global patient populations effectively.